ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NOVARTIND announcements Novartis India announcements and dividends declared NSE

Novartis India Complete list of announcements declared & dividend announcements by Novartis India NOVARTIND

Novartis India NOVARTIND listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Novartis India NOVARTIND

Novartis India eyes therapy-aligned acquisition, Tier 2-3 market push
Pharma company Novartis India Ltd (NIL) plans to pursue disciplined, therapy-aligned acquisitions and deepen its last-mile reach into Tier 2 and Tier 3 markets to drive its next phase of growth, according to the company's annual report. The company's futur
Announcement as on 06 September 2026

Novartis India launches Pluvicto for prostate cancer treatment
Novartis India has launched Pluvicto, the nation's first approved radioligand therapy for eligible prostate cancer patients. This precision radiotherapy precisely targets cancer cells, offering a new treatment approach for metastatic prostate cancer. The t
Announcement as on 15 June 2026

Gainers & Losers: Novartis India and GMDC among 6 stocks in focus on Friday. Here’s why
Novartis India and GMDC led market action on Friday as broader indices recovered, while select stocks saw sharp gains and profit booking.
Announcement as on 20 February 2026

Novartis India Ltd leads losers in 'B' group
Pritish Nandy Communications Ltd, DB (International) Stock Brokers Ltd, Sarthak Metals Ltd and MIC Electronics Ltd are among the other losers in the BSE's 'B' group today, 20 February 2024.
Announcement as on 20 February 2024

Novartis announces strategic review of Novartis India Limited
Drug major Novartis AG on Friday announced a strategic review of Novartis India Ltd, a public company listed on the BSE. The strategic review will include an assessment of the 70.68 per cent shareholding of Novartis AG in the company, the drug firm said in
Announcement as on 16 February 2024

Announcements by Novartis India first page | Next page | Prev page |

NOVARTIND Novartis India current price & indicator signals

Moving Averages for Novartis India

  • 5Day Average: 2005.94
  • 12Day Average: 1983.52
  • 20Day Average: 1993.43
  • 50Day Average: 1799.92
  • 100Day Average: 1639.65
  • 150Day Average: 1392.28
  • 200Day Average: 1235.05

NOVARTIND Indicators & signals

Indicator MACD (12,26,9)

1994.25, 1945.94, 62.91
Indicator MACD is in positive zone

Indicator ADX (14)

32.01, 25.92, 13.35
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 68
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NOVARTIND Novartis India are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
14 Wed Oct 2026 1988.20 1962.20 to 2012.30 -0.17% 0.39 times
13 Tue Oct 2026 1991.60 1940.00 to 2035.00 -1.07% 0.79 times
12 Mon Oct 2026 2013.20 1999.50 to 2105.50 -1.75% 0.69 times
09 Fri Oct 2026 2049.00 1943.10 to 2095.00 3.08% 0.89 times
08 Thu Oct 2026 1987.70 1970.00 to 2057.90 -1.13% 0.62 times
07 Wed Oct 2026 2010.40 2000.00 to 2093.90 -1.99% 1.07 times
06 Tue Oct 2026 2051.20 1936.80 to 2076.20 4.24% 0.92 times
05 Mon Oct 2026 1967.80 1955.00 to 2161.50 0.14% 3.47 times
01 Thu Oct 2026 1965.00 1900.00 to 1986.30 2.4% 0.73 times
30 Wed Sep 2026 1919.00 1910.00 to 2030.70 -0.27% 0.43 times
29 Tue Sep 2026 1924.10 1905.00 to 1990.00 -0.56% 0.39 times
28 Mon Sep 2026 1935.00 1922.00 to 2035.00 -1.56% 0.69 times

Videos related to: NOVARTIND announcements Novartis India announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NOVARTIND announcements Novartis India announcements and dividends declared NSE

 

Back to top